Next generation sequencing in the oncology clinic: the future for the treating physician - J. Rodón

7 April 2017

Genomics in Oncology lecture series invites Jordi Rodón, MD, PhD, Clinical Oncologist and Director of the Research Unit for Molecular Therapy of Cancer at Vall d´Hebron in Barcelona. Dr. Rodón discusses the use of next-generation sequencing to empower the future of precision medicine in oncology drug development. Learn more about genomics in oncology, visit our website: A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. Subscribe to the Illumina video channel View customer spotlight videos View Illumina webinars View Illumina product videos View Illumina support videos

Share this article on